Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002361545 | SCV002658846 | pathogenic | Cardiovascular phenotype | 2020-02-14 | criteria provided, single submitter | clinical testing | The p.Y213* pathogenic mutation (also known as c.639T>A), located in coding exon 5 of the ACVRL1 gene, results from a T to A substitution at nucleotide position 639. This changes the amino acid from a tyrosine to a stop codon within coding exon 5. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |